240 related articles for article (PubMed ID: 33439777)
1. Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG.
Wilson HE; Stanton DA; Rellick S; Geldenhuys W; Pistilli EE
Am J Physiol Cell Physiol; 2021 Apr; 320(4):C577-C590. PubMed ID: 33439777
[TBL] [Abstract][Full Text] [Related]
2. Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator-activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue.
Wilson HE; Rhodes KK; Rodriguez D; Chahal I; Stanton DA; Bohlen J; Davis M; Infante AM; Hazard-Jenkins H; Klinke DJ; Pugacheva EN; Pistilli EE
Clin Cancer Res; 2019 Apr; 25(7):2336-2347. PubMed ID: 30559167
[TBL] [Abstract][Full Text] [Related]
3. Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones.
Lu M; Sarruf DA; Talukdar S; Sharma S; Li P; Bandyopadhyay G; Nalbandian S; Fan W; Gayen JR; Mahata SK; Webster NJ; Schwartz MW; Olefsky JM
Nat Med; 2011 May; 17(5):618-22. PubMed ID: 21532596
[TBL] [Abstract][Full Text] [Related]
4. Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction.
Mallon PW; Sedwell R; Rogers G; Nolan D; Unemori P; Hoy J; Samaras K; Kelleher A; Emery S; Cooper DA; Carr A;
J Infect Dis; 2008 Dec; 198(12):1794-803. PubMed ID: 18954260
[TBL] [Abstract][Full Text] [Related]
5. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P
Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221
[TBL] [Abstract][Full Text] [Related]
6. Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes.
Guigni BA; van der Velden J; Kinsey CM; Carson JA; Toth MJ
Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E22-E32. PubMed ID: 31689144
[TBL] [Abstract][Full Text] [Related]
7. Oleanolic acid induces a dual agonist action on PPARγ/α and GLUT4 translocation: A pentacyclic triterpene for dyslipidemia and type 2 diabetes.
Loza-Rodríguez H; Estrada-Soto S; Alarcón-Aguilar FJ; Huang F; Aquino-Jarquín G; Fortis-Barrera Á; Giacoman-Martínez A; Almanza-Pérez JC
Eur J Pharmacol; 2020 Sep; 883():173252. PubMed ID: 32534078
[TBL] [Abstract][Full Text] [Related]
8. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype.
Wenz T; Diaz F; Spiegelman BM; Moraes CT
Cell Metab; 2008 Sep; 8(3):249-56. PubMed ID: 18762025
[TBL] [Abstract][Full Text] [Related]
9. Cachectic skeletal muscle response to a novel bout of low-frequency stimulation.
Puppa MJ; Murphy EA; Fayad R; Hand GA; Carson JA
J Appl Physiol (1985); 2014 Apr; 116(8):1078-87. PubMed ID: 24610533
[TBL] [Abstract][Full Text] [Related]
10. Role of peroxisome proliferator activated receptor-gamma in bacillus Calmette-Guérin bladder cancer therapy.
Langle Y; Lodillinsky C; Belgorosky D; Sandes EO; Eiján AM
J Urol; 2012 Dec; 188(6):2384-90. PubMed ID: 23088980
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
Meshkani R; Sadeghi A; Taheripak G; Zarghooni M; Gerayesh-Nejad S; Bakhtiyari S
Cell Biochem Funct; 2014 Dec; 32(8):683-91. PubMed ID: 25431031
[TBL] [Abstract][Full Text] [Related]
12. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
13. Thyroid Hormone Stimulation of Autophagy Is Essential for Mitochondrial Biogenesis and Activity in Skeletal Muscle.
Lesmana R; Sinha RA; Singh BK; Zhou J; Ohba K; Wu Y; Yau WW; Bay BH; Yen PM
Endocrinology; 2016 Jan; 157(1):23-38. PubMed ID: 26562261
[TBL] [Abstract][Full Text] [Related]
14. PPARG regulates gonadotropin-releasing hormone signaling in LbetaT2 cells in vitro and pituitary gonadotroph function in vivo in mice.
Sharma S; Sharma PM; Mistry DS; Chang RJ; Olefsky JM; Mellon PL; Webster NJ
Biol Reprod; 2011 Mar; 84(3):466-75. PubMed ID: 21076077
[TBL] [Abstract][Full Text] [Related]
15. Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial.
Kopp TI; Jensen DM; Ravn-Haren G; Cohen A; Sommer HM; Dragsted LO; Tjonneland A; Hougaard DM; Vogel U
BMC Cancer; 2016 Apr; 16():283. PubMed ID: 27102200
[TBL] [Abstract][Full Text] [Related]
16. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.
Brun S; Carmona MC; Mampel T; Viñas O; Giralt M; Iglesias R; Villarroya F
Diabetes; 1999 Jun; 48(6):1217-22. PubMed ID: 10342807
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1)- and estrogen-related receptor (ERR)-induced regulator in muscle 1 (Perm1) is a tissue-specific regulator of oxidative capacity in skeletal muscle cells.
Cho Y; Hazen BC; Russell AP; Kralli A
J Biol Chem; 2013 Aug; 288(35):25207-25218. PubMed ID: 23836911
[TBL] [Abstract][Full Text] [Related]
18. Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.
Cha BS; Ciaraldi TP; Park KS; Carter L; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E151-9. PubMed ID: 15727952
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue.
Bohlen J; McLaughlin SL; Hazard-Jenkins H; Infante AM; Montgomery C; Davis M; Pistilli EE
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):701-714. PubMed ID: 29582584
[TBL] [Abstract][Full Text] [Related]
20. Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
Fuster G; Busquets S; Ametller E; Olivan M; Almendro V; de Oliveira CC; Figueras M; López-Soriano FJ; Argilés JM
Cancer Res; 2007 Jul; 67(13):6512-9. PubMed ID: 17616713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
